Biotech Business - February 28, 2020
Cartana appoints a new CEO
Swedish biotechnology start-up Cartana has announced the appointment of Mårten Winge as CEO. A spin-out from the SciLifeLab, Cartana has launched a new spatial cell type mapping service and reagent kits for neuroscientists. This enables gene expression to be mapped in tissue samples for the first time at single cell resolution, opening up new levels […]
Biotech Business - February 24, 2020
Changes in Xbrane’s management team
Xbrane Biopharma strengthens its management team to better equip the company for commercialization of its biosimilars and Paolo Sarmientos steps out of the management team. Xbrane Biopharma is advancing its portfolio of biosimilars with targeted launch of leading product Xlucane (Lucentis biosimilar) in 2022. To better equip the company for commercialization of its biosimilars Xbrane […]
In a new job - February 21, 2020
SciLifeLab fellows appointed Future Research Leaders by the Swedish Foundation for Strategic Research
The Swedish Foundation for Strategic Research (SSF) has appointed the seventh generation of Future Research Leaders (FFL). From the 227 applications, 10 men and 10 women were selected, among them SciLifeLab Fellows Simon Elsässer (Karolinska Institutet) and Mikael Sellin (Uppsala University). The goal is to support and promote young scientists into becoming the future leaders […]
In a new job - February 21, 2020
Olli Pietiläinen recruited new Group Leader to Neuroscience Center in Helsinki
Olli Pietiläinen has been appointed as a group leader to the Neuroscience Center (NC) in Helsinki. Pietiläinen received his PhD in Molecular Genetics from the University of Helsinki, while also spending several years at the Wellcome Trust Sanger Institute in Cambridge, UK. For his postdoc, Pietiläinen moved to the Broad Institute and Harvard University, Cambridge, […]
In a new job - February 17, 2020
Oasmia appoints new CEO
The Board of Oasmia Pharmaceutical has appointed Francois Martelet as the new CEO. Martelet has extensive international experience of leading pharmaceutical companies. He replaces Sven Rohmann, who has been acting CEO during a crucial transition period. Rohmann remains in his position as Board member and will continue to play an active role in the company’s […]
In a new job - February 14, 2020
AroCell appoints Cecilia Ahlin as Chief Medical Officer
AroCell has announced that Cecilia Ahlin joins the management team as Chief Medical Officer. Cecilia Ahlin will lead and develop AroCell’s clinical strategy with focus on getting more clinical evidence for the use of TK1 as a biomarker in cancer treatment. Still an active oncologist treating patients Ahlin has over 20 years of experience treating […]
